Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-02-24 @ 10:06 AM
Study NCT ID:
NCT00240357
Status:
WITHDRAWN
Last Update Posted:
2009-03-26
First Post:
2005-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement of LDL Goals. - Denmark
Status:
WITHDRAWN
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study cancelled prior to FSI
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine whether an Internet based compliance tool is superior to common diet counselling in patients with hypercholesterolemia.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| Orbital | None | None | View |